The results reported here that two different CRC cell lines use the same proteasome-dependent pathway suggest that this may be the prevalent one activated by Qc in this tumor type and adds to the interference with the miR-27a-ZBTB10 axis described above. The gene discussed is ZBTB10; the disease is neoplasm.